TAG:
tamtron
Ex-IMPATH Executives Face Criminal Charges
By Robert Michel | From the Volume XII No. 6 – April 18, 2005 Issue
CEO SUMMARY: With the announcement by Federal prosecutors of criminal and civil actions against a total of seven ex-IMPATH executives, IMPATH becomes the laboratory industry’s worst criminal scandal. Federal prosecutors contend these executives, during their employment at IMPATH, engine…
New Competitors Line Up In Oncology Marketplace
By Robert Michel | From the Volume XI No. 4 – March 15, 2004 Issue
CEO SUMMARY: Local pathology groups are advised to more closely track developments in the national market for oncology testing. Not only is big money targeting cancer testing, but a number of nimble, entrepreneurial start-up companies have begun to compete for specimens. Genzyme’s acqui…
When Laboratory Vendors Go Bankrupt
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
BANKRUPTCY AMONG VENDORS AND SUPPLIERS in the laboratory industry is an uncommon event. Since it is so rare, that is one less issue about which laboratory directors and pathologists must worry. However, occasionally there are reminders that it is good management practice to track the financial stab…
Free of IMPATH, Tamtron Ready For A New Future
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
CEO SUMMARY: Tamtron’s fortunes look much brighter with its acquisition by IMPAC Medical Systems, Inc., a healthcare information vendor with existing products for radiation oncology, medical oncology, and urology. IMPAC’s strategy is to create a “total solution” for oncology. That…
Tamtron Plans Comeback After IMPATH’s Chapt. 11
By Robert Michel | From the Volume X No. 15 – November 10, 2003 Issue
CEO SUMMARY: It was only 21 months ago that IMPATH acquired Tamtron. Both companies had high expectations for the relationship. But with IMPATH now in Chapter 11 bankruptcy and facing an unclear future, Tamtron is now an attractive asset for potential buyers who want to enter the anatomic…
Chapter 11 Bankruptcy Filed by IMPATH, Inc.
By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue
CEO SUMMARY: To the surprise of very few, IMPATH, Inc. filed for Chapter 11 bankruptcy protection. During 2003, most of IMPATH’s key executives departed as different problems within the company became known. IMPATH’s new executive leadership is dealing with a host of difficult issues….
Dynacare, LabCorp, IMPATH, Visible Genetics, Abbott Labs
By Robert Michel | From the Volume IX No. 6 – April 22, 2002 Issue
ACTIVITY AT DYNACARE HINTS AT POSSIBLE SALE, LABCORP MAY BE BUYER With Quest Diagnostics Incorporated snapping up independent lab companies right and left in recent months, the question asked by many is “Where’s Laboratory Corporation of America?” On …
ARUP Labs, ProxyMed, Unilab, Quest Diagnostics, Ventana, , Misys Molecular Diagnostics, WebMD, Varian
By Robert Michel | From the Volume IX No. 3 – February 18, 2002 Issue
ARUP TO USE PROXYMED FOR BROWSER-BASED TEST ORDERS & RESULTS ARUP LABORATORIES, INC. and ProxyMed, Inc. signed an agreement that makes ProxyMed’s ProxyLabSM the preferred product for browser-based lab test ordering between physicians and ARUP’s hospi…
IMPATH Buys Tamtron In Surprise Decision
By Robert Michel | From the Volume IX No. 2 – January 28, 2002 Issue
CEO SUMMARY: In an unexpected announcement, IMPATH, Inc. announced it would purchase Tamtron Corp., the largest remaining independent vendor of anatomic pathology systems. It was just months earlier that Cerner Corporation acquired Dynamic Healthcare Technologies, Inc. and its CoPath™ p…
Lab “Home Brews” Web Solution for Test Results
CEO SUMMARY: Internet-enabled lab test ordering and results reporting may help independent commercial labs and hospital laboratory outreach programs become more competitive against the two blood brothers. In eastern Pennsylvania, Clinical Laboratories, Inc. introduced Web-based lab test r…
CURRENT ISSUE
Volume XXXI, No. 13 – September 23, 2024
The Dark Report has visited several companies in Europe to see what innovations they have developed that might be coming to laboratories and pathology groups in the U.S. Also, hospital lab outreach businesses are still valuable commodities in the eyes of the Blood Brothers. In addition, The Dark Report delivers the 2nd quarter earnings reports of the top global IVD companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized